TrialStem cell research & therapy2023

Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).

Kazuya Ichikado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.